nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ADRB2—prostate cancer	0.484	1	CbGaD
Penbutolol—ORM1—Abiraterone—prostate cancer	0.296	1	CbGbCtD
Penbutolol—Levobunolol—ADRB2—prostate cancer	0.000848	0.134	CrCbGaD
Penbutolol—Timolol—ADRB2—prostate cancer	0.000809	0.128	CrCbGaD
Penbutolol—Amnesia—Estradiol—prostate cancer	0.000802	0.00435	CcSEcCtD
Penbutolol—Fatigue—Flutamide—prostate cancer	0.000799	0.00433	CcSEcCtD
Penbutolol—Pain—Nilutamide—prostate cancer	0.000796	0.00432	CcSEcCtD
Penbutolol—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.00077	0.00418	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Goserelin—prostate cancer	0.000764	0.00414	CcSEcCtD
Penbutolol—Erectile dysfunction—Goserelin—prostate cancer	0.000757	0.00411	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Conjugated Estrogens—prostate cancer	0.000756	0.0041	CcSEcCtD
Penbutolol—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.000754	0.00409	CcSEcCtD
Penbutolol—Insomnia—Degarelix—prostate cancer	0.000752	0.00408	CcSEcCtD
Penbutolol—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000748	0.00406	CcSEcCtD
Penbutolol—Affect lability—Estradiol—prostate cancer	0.000742	0.00402	CcSEcCtD
Penbutolol—Dyspnoea—Degarelix—prostate cancer	0.000741	0.00402	CcSEcCtD
Penbutolol—Body temperature increased—Nilutamide—prostate cancer	0.000736	0.00399	CcSEcCtD
Penbutolol—Oropharyngeal pain—Docetaxel—prostate cancer	0.000735	0.00399	CcSEcCtD
Penbutolol—Asthenia—Abiraterone—prostate cancer	0.000731	0.00396	CcSEcCtD
Penbutolol—Depression—Goserelin—prostate cancer	0.00073	0.00396	CcSEcCtD
Penbutolol—Depression—Conjugated Estrogens—prostate cancer	0.000724	0.00393	CcSEcCtD
Penbutolol—Carteolol—ADRB2—prostate cancer	0.000721	0.114	CrCbGaD
Penbutolol—Cough—Bicalutamide—prostate cancer	0.000718	0.0039	CcSEcCtD
Penbutolol—Diarrhoea—Estramustine—prostate cancer	0.000717	0.00389	CcSEcCtD
Penbutolol—Fatigue—Degarelix—prostate cancer	0.000717	0.00389	CcSEcCtD
Penbutolol—Mood swings—Estradiol—prostate cancer	0.000714	0.00387	CcSEcCtD
Penbutolol—Oropharyngeal pain—Capecitabine—prostate cancer	0.000712	0.00386	CcSEcCtD
Penbutolol—Pain—Degarelix—prostate cancer	0.000711	0.00386	CcSEcCtD
Penbutolol—Alopecia—Ethinyl Estradiol—prostate cancer	0.000706	0.00383	CcSEcCtD
Penbutolol—Sweating—Goserelin—prostate cancer	0.000702	0.00381	CcSEcCtD
Penbutolol—Dyspnoea—Cabazitaxel—prostate cancer	0.000698	0.00379	CcSEcCtD
Penbutolol—Diarrhoea—Abiraterone—prostate cancer	0.000697	0.00378	CcSEcCtD
Penbutolol—Timolol—CYP2C19—prostate cancer	0.000696	0.11	CrCbGaD
Penbutolol—Dyspepsia—Cabazitaxel—prostate cancer	0.000689	0.00374	CcSEcCtD
Penbutolol—Fatigue—Cabazitaxel—prostate cancer	0.000675	0.00366	CcSEcCtD
Penbutolol—Pain—Cabazitaxel—prostate cancer	0.00067	0.00363	CcSEcCtD
Penbutolol—Asthenia—Nilutamide—prostate cancer	0.000668	0.00362	CcSEcCtD
Penbutolol—Asthenia—Flutamide—prostate cancer	0.000665	0.00361	CcSEcCtD
Penbutolol—Dizziness—Estrone—prostate cancer	0.000662	0.00359	CcSEcCtD
Penbutolol—Body temperature increased—Degarelix—prostate cancer	0.000657	0.00356	CcSEcCtD
Penbutolol—Headache—Estramustine—prostate cancer	0.000657	0.00356	CcSEcCtD
Penbutolol—Hyperhidrosis—Bicalutamide—prostate cancer	0.000649	0.00352	CcSEcCtD
Penbutolol—Nadolol—ADRB2—prostate cancer	0.000643	0.102	CrCbGaD
Penbutolol—Diarrhoea—Nilutamide—prostate cancer	0.000637	0.00345	CcSEcCtD
Penbutolol—Diarrhoea—Flutamide—prostate cancer	0.000634	0.00344	CcSEcCtD
Penbutolol—Headache—Estrone—prostate cancer	0.000628	0.0034	CcSEcCtD
Penbutolol—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000627	0.0034	CcSEcCtD
Penbutolol—Nausea—Estramustine—prostate cancer	0.000623	0.00338	CcSEcCtD
Penbutolol—Body temperature increased—Cabazitaxel—prostate cancer	0.000619	0.00336	CcSEcCtD
Penbutolol—Dizziness—Nilutamide—prostate cancer	0.000615	0.00334	CcSEcCtD
Penbutolol—Bupranolol—ADRB2—prostate cancer	0.000613	0.0971	CrCbGaD
Penbutolol—Dizziness—Flutamide—prostate cancer	0.000613	0.00332	CcSEcCtD
Penbutolol—Insomnia—Bicalutamide—prostate cancer	0.000607	0.0033	CcSEcCtD
Penbutolol—Cough—Ethinyl Estradiol—prostate cancer	0.000607	0.00329	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Estradiol—prostate cancer	0.000605	0.00328	CcSEcCtD
Penbutolol—Dyspnoea—Bicalutamide—prostate cancer	0.000599	0.00325	CcSEcCtD
Penbutolol—Asthenia—Degarelix—prostate cancer	0.000596	0.00324	CcSEcCtD
Penbutolol—Nausea—Estrone—prostate cancer	0.000595	0.00323	CcSEcCtD
Penbutolol—Dyspepsia—Bicalutamide—prostate cancer	0.000591	0.00321	CcSEcCtD
Penbutolol—Rash erythematous—Epirubicin—prostate cancer	0.000589	0.0032	CcSEcCtD
Penbutolol—Headache—Nilutamide—prostate cancer	0.000583	0.00316	CcSEcCtD
Penbutolol—Alopecia—Goserelin—prostate cancer	0.000581	0.00315	CcSEcCtD
Penbutolol—Headache—Flutamide—prostate cancer	0.00058	0.00315	CcSEcCtD
Penbutolol—Depression—Estradiol—prostate cancer	0.000579	0.00314	CcSEcCtD
Penbutolol—Fatigue—Bicalutamide—prostate cancer	0.000579	0.00314	CcSEcCtD
Penbutolol—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000578	0.00314	CcSEcCtD
Penbutolol—Alopecia—Conjugated Estrogens—prostate cancer	0.000576	0.00312	CcSEcCtD
Penbutolol—Pain—Bicalutamide—prostate cancer	0.000574	0.00312	CcSEcCtD
Penbutolol—Diarrhoea—Degarelix—prostate cancer	0.000569	0.00309	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Mitoxantrone—prostate cancer	0.000564	0.00306	CcSEcCtD
Penbutolol—Asthenia—Cabazitaxel—prostate cancer	0.000562	0.00305	CcSEcCtD
Penbutolol—Erectile dysfunction—Mitoxantrone—prostate cancer	0.000559	0.00303	CcSEcCtD
Penbutolol—Nausea—Nilutamide—prostate cancer	0.000553	0.003	CcSEcCtD
Penbutolol—Nausea—Flutamide—prostate cancer	0.00055	0.00299	CcSEcCtD
Penbutolol—Dizziness—Degarelix—prostate cancer	0.00055	0.00298	CcSEcCtD
Penbutolol—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000548	0.00297	CcSEcCtD
Penbutolol—Rash erythematous—Doxorubicin—prostate cancer	0.000545	0.00296	CcSEcCtD
Penbutolol—Diarrhoea—Cabazitaxel—prostate cancer	0.000536	0.00291	CcSEcCtD
Penbutolol—Body temperature increased—Bicalutamide—prostate cancer	0.000531	0.00288	CcSEcCtD
Penbutolol—Headache—Degarelix—prostate cancer	0.000521	0.00283	CcSEcCtD
Penbutolol—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000519	0.00282	CcSEcCtD
Penbutolol—Sweating—Mitoxantrone—prostate cancer	0.000519	0.00281	CcSEcCtD
Penbutolol—Dizziness—Cabazitaxel—prostate cancer	0.000518	0.00281	CcSEcCtD
Penbutolol—Oxprenolol—ADRB2—prostate cancer	0.000514	0.0814	CrCbGaD
Penbutolol—Agranulocytosis—Mitoxantrone—prostate cancer	0.000505	0.00274	CcSEcCtD
Penbutolol—Amnesia—Capecitabine—prostate cancer	0.0005	0.00271	CcSEcCtD
Penbutolol—Cough—Goserelin—prostate cancer	0.0005	0.00271	CcSEcCtD
Penbutolol—Cough—Conjugated Estrogens—prostate cancer	0.000495	0.00268	CcSEcCtD
Penbutolol—Bradycardia—Mitoxantrone—prostate cancer	0.000495	0.00268	CcSEcCtD
Penbutolol—Nausea—Degarelix—prostate cancer	0.000494	0.00268	CcSEcCtD
Penbutolol—Headache—Cabazitaxel—prostate cancer	0.000491	0.00266	CcSEcCtD
Penbutolol—Fatigue—Ethinyl Estradiol—prostate cancer	0.000489	0.00266	CcSEcCtD
Penbutolol—Asthenia—Bicalutamide—prostate cancer	0.000482	0.00261	CcSEcCtD
Penbutolol—Alprenolol—ADRB2—prostate cancer	0.00047	0.0744	CrCbGaD
Penbutolol—Nausea—Cabazitaxel—prostate cancer	0.000465	0.00252	CcSEcCtD
Penbutolol—Atrioventricular block—Epirubicin—prostate cancer	0.000465	0.00252	CcSEcCtD
Penbutolol—Alopecia—Estradiol—prostate cancer	0.000461	0.0025	CcSEcCtD
Penbutolol—Diarrhoea—Bicalutamide—prostate cancer	0.00046	0.00249	CcSEcCtD
Penbutolol—Hyperhidrosis—Goserelin—prostate cancer	0.000452	0.00245	CcSEcCtD
Penbutolol—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000449	0.00244	CcSEcCtD
Penbutolol—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000447	0.00243	CcSEcCtD
Penbutolol—Amnesia—Prednisone—prostate cancer	0.000446	0.00242	CcSEcCtD
Penbutolol—Mood swings—Capecitabine—prostate cancer	0.000445	0.00242	CcSEcCtD
Penbutolol—Dizziness—Bicalutamide—prostate cancer	0.000444	0.00241	CcSEcCtD
Penbutolol—Atrioventricular block—Doxorubicin—prostate cancer	0.00043	0.00233	CcSEcCtD
Penbutolol—Alopecia—Mitoxantrone—prostate cancer	0.000429	0.00233	CcSEcCtD
Penbutolol—Insomnia—Goserelin—prostate cancer	0.000423	0.00229	CcSEcCtD
Penbutolol—Headache—Bicalutamide—prostate cancer	0.000421	0.00228	CcSEcCtD
Penbutolol—Agranulocytosis—Etoposide—prostate cancer	0.00042	0.00228	CcSEcCtD
Penbutolol—Insomnia—Conjugated Estrogens—prostate cancer	0.000419	0.00227	CcSEcCtD
Penbutolol—Dyspnoea—Goserelin—prostate cancer	0.000417	0.00226	CcSEcCtD
Penbutolol—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000413	0.00224	CcSEcCtD
Penbutolol—Affect lability—Prednisone—prostate cancer	0.000412	0.00224	CcSEcCtD
Penbutolol—Dyspepsia—Goserelin—prostate cancer	0.000411	0.00223	CcSEcCtD
Penbutolol—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000407	0.00221	CcSEcCtD
Penbutolol—Asthenia—Ethinyl Estradiol—prostate cancer	0.000407	0.00221	CcSEcCtD
Penbutolol—Fatigue—Goserelin—prostate cancer	0.000403	0.00219	CcSEcCtD
Penbutolol—Pain—Goserelin—prostate cancer	0.0004	0.00217	CcSEcCtD
Penbutolol—Fatigue—Conjugated Estrogens—prostate cancer	0.000399	0.00216	CcSEcCtD
Penbutolol—Nausea—Bicalutamide—prostate cancer	0.000399	0.00216	CcSEcCtD
Penbutolol—Mood swings—Prednisone—prostate cancer	0.000397	0.00215	CcSEcCtD
Penbutolol—Cough—Estradiol—prostate cancer	0.000396	0.00215	CcSEcCtD
Penbutolol—Pain—Conjugated Estrogens—prostate cancer	0.000396	0.00215	CcSEcCtD
Penbutolol—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000388	0.00211	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000378	0.00205	CcSEcCtD
Penbutolol—Dizziness—Ethinyl Estradiol—prostate cancer	0.000375	0.00204	CcSEcCtD
Penbutolol—Body temperature increased—Goserelin—prostate cancer	0.000369	0.002	CcSEcCtD
Penbutolol—Cough—Mitoxantrone—prostate cancer	0.000369	0.002	CcSEcCtD
Penbutolol—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000366	0.00199	CcSEcCtD
Penbutolol—Depression—Capecitabine—prostate cancer	0.000361	0.00196	CcSEcCtD
Penbutolol—Hyperhidrosis—Estradiol—prostate cancer	0.000358	0.00194	CcSEcCtD
Penbutolol—Alopecia—Etoposide—prostate cancer	0.000357	0.00194	CcSEcCtD
Penbutolol—Headache—Ethinyl Estradiol—prostate cancer	0.000356	0.00193	CcSEcCtD
Penbutolol—Agranulocytosis—Docetaxel—prostate cancer	0.000349	0.00189	CcSEcCtD
Penbutolol—Agranulocytosis—Capecitabine—prostate cancer	0.000338	0.00183	CcSEcCtD
Penbutolol—Nausea—Ethinyl Estradiol—prostate cancer	0.000337	0.00183	CcSEcCtD
Penbutolol—Asthenia—Goserelin—prostate cancer	0.000335	0.00182	CcSEcCtD
Penbutolol—Insomnia—Estradiol—prostate cancer	0.000335	0.00182	CcSEcCtD
Penbutolol—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000334	0.00181	CcSEcCtD
Penbutolol—Erectile dysfunction—Prednisone—prostate cancer	0.000333	0.00181	CcSEcCtD
Penbutolol—Asthenia—Conjugated Estrogens—prostate cancer	0.000332	0.0018	CcSEcCtD
Penbutolol—Bradycardia—Capecitabine—prostate cancer	0.000331	0.0018	CcSEcCtD
Penbutolol—Dyspnoea—Estradiol—prostate cancer	0.00033	0.00179	CcSEcCtD
Penbutolol—Dyspepsia—Estradiol—prostate cancer	0.000326	0.00177	CcSEcCtD
Penbutolol—Affect lability—Epirubicin—prostate cancer	0.000322	0.00175	CcSEcCtD
Penbutolol—Depression—Prednisone—prostate cancer	0.000322	0.00175	CcSEcCtD
Penbutolol—Diarrhoea—Goserelin—prostate cancer	0.00032	0.00173	CcSEcCtD
Penbutolol—Fatigue—Estradiol—prostate cancer	0.000319	0.00173	CcSEcCtD
Penbutolol—Pain—Estradiol—prostate cancer	0.000317	0.00172	CcSEcCtD
Penbutolol—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000317	0.00172	CcSEcCtD
Penbutolol—Mood swings—Epirubicin—prostate cancer	0.00031	0.00168	CcSEcCtD
Penbutolol—Dizziness—Goserelin—prostate cancer	0.000309	0.00168	CcSEcCtD
Penbutolol—Dyspnoea—Mitoxantrone—prostate cancer	0.000308	0.00167	CcSEcCtD
Penbutolol—Cough—Etoposide—prostate cancer	0.000307	0.00167	CcSEcCtD
Penbutolol—Dizziness—Conjugated Estrogens—prostate cancer	0.000306	0.00166	CcSEcCtD
Penbutolol—Dyspepsia—Mitoxantrone—prostate cancer	0.000304	0.00165	CcSEcCtD
Penbutolol—Affect lability—Doxorubicin—prostate cancer	0.000298	0.00162	CcSEcCtD
Penbutolol—Fatigue—Mitoxantrone—prostate cancer	0.000298	0.00161	CcSEcCtD
Penbutolol—Alopecia—Docetaxel—prostate cancer	0.000297	0.00161	CcSEcCtD
Penbutolol—Pain—Mitoxantrone—prostate cancer	0.000295	0.0016	CcSEcCtD
Penbutolol—Bradycardia—Prednisone—prostate cancer	0.000295	0.0016	CcSEcCtD
Penbutolol—Body temperature increased—Estradiol—prostate cancer	0.000293	0.00159	CcSEcCtD
Penbutolol—Headache—Goserelin—prostate cancer	0.000293	0.00159	CcSEcCtD
Penbutolol—Headache—Conjugated Estrogens—prostate cancer	0.00029	0.00157	CcSEcCtD
Penbutolol—Alopecia—Capecitabine—prostate cancer	0.000287	0.00156	CcSEcCtD
Penbutolol—Mood swings—Doxorubicin—prostate cancer	0.000287	0.00156	CcSEcCtD
Penbutolol—Propranolol—CYP3A5—prostate cancer	0.000279	0.0442	CrCbGaD
Penbutolol—Nausea—Goserelin—prostate cancer	0.000278	0.00151	CcSEcCtD
Penbutolol—Hyperhidrosis—Etoposide—prostate cancer	0.000278	0.00151	CcSEcCtD
Penbutolol—Nausea—Conjugated Estrogens—prostate cancer	0.000275	0.00149	CcSEcCtD
Penbutolol—Body temperature increased—Mitoxantrone—prostate cancer	0.000273	0.00148	CcSEcCtD
Penbutolol—Asthenia—Estradiol—prostate cancer	0.000266	0.00144	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000263	0.00143	CcSEcCtD
Penbutolol—Dyspnoea—Etoposide—prostate cancer	0.000256	0.00139	CcSEcCtD
Penbutolol—Alopecia—Prednisone—prostate cancer	0.000256	0.00139	CcSEcCtD
Penbutolol—Cough—Docetaxel—prostate cancer	0.000255	0.00138	CcSEcCtD
Penbutolol—Diarrhoea—Estradiol—prostate cancer	0.000253	0.00138	CcSEcCtD
Penbutolol—Asthenia—Mitoxantrone—prostate cancer	0.000248	0.00134	CcSEcCtD
Penbutolol—Fatigue—Etoposide—prostate cancer	0.000248	0.00134	CcSEcCtD
Penbutolol—Cough—Capecitabine—prostate cancer	0.000247	0.00134	CcSEcCtD
Penbutolol—Pain—Etoposide—prostate cancer	0.000245	0.00133	CcSEcCtD
Penbutolol—Dizziness—Estradiol—prostate cancer	0.000245	0.00133	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000243	0.00132	CcSEcCtD
Penbutolol—Sweating—Epirubicin—prostate cancer	0.000242	0.00131	CcSEcCtD
Penbutolol—Diarrhoea—Mitoxantrone—prostate cancer	0.000236	0.00128	CcSEcCtD
Penbutolol—Agranulocytosis—Epirubicin—prostate cancer	0.000235	0.00128	CcSEcCtD
Penbutolol—Headache—Estradiol—prostate cancer	0.000232	0.00126	CcSEcCtD
Penbutolol—Bradycardia—Epirubicin—prostate cancer	0.000231	0.00125	CcSEcCtD
Penbutolol—Body temperature increased—Etoposide—prostate cancer	0.000227	0.00123	CcSEcCtD
Penbutolol—Sweating—Doxorubicin—prostate cancer	0.000224	0.00121	CcSEcCtD
Penbutolol—Hyperhidrosis—Capecitabine—prostate cancer	0.000223	0.00121	CcSEcCtD
Penbutolol—Propranolol—ADRB2—prostate cancer	0.00022	0.0349	CrCbGaD
Penbutolol—Nausea—Estradiol—prostate cancer	0.00022	0.00119	CcSEcCtD
Penbutolol—Agranulocytosis—Doxorubicin—prostate cancer	0.000218	0.00118	CcSEcCtD
Penbutolol—Headache—Mitoxantrone—prostate cancer	0.000216	0.00117	CcSEcCtD
Penbutolol—Insomnia—Docetaxel—prostate cancer	0.000216	0.00117	CcSEcCtD
Penbutolol—Bradycardia—Doxorubicin—prostate cancer	0.000213	0.00116	CcSEcCtD
Penbutolol—Dyspnoea—Docetaxel—prostate cancer	0.000213	0.00115	CcSEcCtD
Penbutolol—Dyspepsia—Docetaxel—prostate cancer	0.00021	0.00114	CcSEcCtD
Penbutolol—Insomnia—Capecitabine—prostate cancer	0.000209	0.00113	CcSEcCtD
Penbutolol—Asthenia—Etoposide—prostate cancer	0.000206	0.00112	CcSEcCtD
Penbutolol—Dyspnoea—Capecitabine—prostate cancer	0.000206	0.00112	CcSEcCtD
Penbutolol—Fatigue—Docetaxel—prostate cancer	0.000206	0.00112	CcSEcCtD
Penbutolol—Nausea—Mitoxantrone—prostate cancer	0.000205	0.00111	CcSEcCtD
Penbutolol—Pain—Docetaxel—prostate cancer	0.000204	0.00111	CcSEcCtD
Penbutolol—Dyspepsia—Capecitabine—prostate cancer	0.000203	0.0011	CcSEcCtD
Penbutolol—Alopecia—Epirubicin—prostate cancer	0.0002	0.00109	CcSEcCtD
Penbutolol—Fatigue—Capecitabine—prostate cancer	0.000199	0.00108	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisone—prostate cancer	0.000199	0.00108	CcSEcCtD
Penbutolol—Pain—Capecitabine—prostate cancer	0.000198	0.00107	CcSEcCtD
Penbutolol—Diarrhoea—Etoposide—prostate cancer	0.000196	0.00107	CcSEcCtD
Penbutolol—Dizziness—Etoposide—prostate cancer	0.00019	0.00103	CcSEcCtD
Penbutolol—Propranolol—CYP2C19—prostate cancer	0.00019	0.0301	CrCbGaD
Penbutolol—Propranolol—CYP1A1—prostate cancer	0.000189	0.03	CrCbGaD
Penbutolol—Body temperature increased—Docetaxel—prostate cancer	0.000189	0.00102	CcSEcCtD
Penbutolol—Insomnia—Prednisone—prostate cancer	0.000186	0.00101	CcSEcCtD
Penbutolol—Alopecia—Doxorubicin—prostate cancer	0.000185	0.001	CcSEcCtD
Penbutolol—Body temperature increased—Capecitabine—prostate cancer	0.000183	0.000991	CcSEcCtD
Penbutolol—Dyspepsia—Prednisone—prostate cancer	0.000181	0.000983	CcSEcCtD
Penbutolol—Headache—Etoposide—prostate cancer	0.00018	0.000976	CcSEcCtD
Penbutolol—Fatigue—Prednisone—prostate cancer	0.000177	0.000962	CcSEcCtD
Penbutolol—Cough—Epirubicin—prostate cancer	0.000172	0.000934	CcSEcCtD
Penbutolol—Asthenia—Docetaxel—prostate cancer	0.000171	0.000929	CcSEcCtD
Penbutolol—Nausea—Etoposide—prostate cancer	0.000171	0.000925	CcSEcCtD
Penbutolol—Asthenia—Capecitabine—prostate cancer	0.000166	0.000899	CcSEcCtD
Penbutolol—Diarrhoea—Docetaxel—prostate cancer	0.000163	0.000886	CcSEcCtD
Penbutolol—Body temperature increased—Prednisone—prostate cancer	0.000163	0.000883	CcSEcCtD
Penbutolol—Cough—Doxorubicin—prostate cancer	0.000159	0.000864	CcSEcCtD
Penbutolol—Diarrhoea—Capecitabine—prostate cancer	0.000158	0.000858	CcSEcCtD
Penbutolol—Dizziness—Docetaxel—prostate cancer	0.000158	0.000856	CcSEcCtD
Penbutolol—Hyperhidrosis—Epirubicin—prostate cancer	0.000156	0.000844	CcSEcCtD
Penbutolol—Dizziness—Capecitabine—prostate cancer	0.000153	0.000829	CcSEcCtD
Penbutolol—Headache—Docetaxel—prostate cancer	0.000149	0.000811	CcSEcCtD
Penbutolol—Asthenia—Prednisone—prostate cancer	0.000148	0.000801	CcSEcCtD
Penbutolol—Insomnia—Epirubicin—prostate cancer	0.000146	0.00079	CcSEcCtD
Penbutolol—Headache—Capecitabine—prostate cancer	0.000145	0.000785	CcSEcCtD
Penbutolol—Hyperhidrosis—Doxorubicin—prostate cancer	0.000144	0.000781	CcSEcCtD
Penbutolol—Dyspnoea—Epirubicin—prostate cancer	0.000143	0.000778	CcSEcCtD
Penbutolol—Nausea—Docetaxel—prostate cancer	0.000142	0.000769	CcSEcCtD
Penbutolol—Dyspepsia—Epirubicin—prostate cancer	0.000142	0.000769	CcSEcCtD
Penbutolol—Diarrhoea—Prednisone—prostate cancer	0.000141	0.000764	CcSEcCtD
Penbutolol—Fatigue—Epirubicin—prostate cancer	0.000139	0.000753	CcSEcCtD
Penbutolol—Pain—Epirubicin—prostate cancer	0.000138	0.000747	CcSEcCtD
Penbutolol—Nausea—Capecitabine—prostate cancer	0.000137	0.000744	CcSEcCtD
Penbutolol—Dizziness—Prednisone—prostate cancer	0.000136	0.000738	CcSEcCtD
Penbutolol—Insomnia—Doxorubicin—prostate cancer	0.000135	0.000731	CcSEcCtD
Penbutolol—Dyspnoea—Doxorubicin—prostate cancer	0.000133	0.00072	CcSEcCtD
Penbutolol—Dyspepsia—Doxorubicin—prostate cancer	0.000131	0.000711	CcSEcCtD
Penbutolol—Headache—Prednisone—prostate cancer	0.000129	0.000699	CcSEcCtD
Penbutolol—Fatigue—Doxorubicin—prostate cancer	0.000128	0.000697	CcSEcCtD
Penbutolol—Pain—Doxorubicin—prostate cancer	0.000127	0.000691	CcSEcCtD
Penbutolol—Body temperature increased—Epirubicin—prostate cancer	0.000127	0.00069	CcSEcCtD
Penbutolol—Nausea—Prednisone—prostate cancer	0.000122	0.000663	CcSEcCtD
Penbutolol—Propranolol—CYP3A4—prostate cancer	0.000121	0.0191	CrCbGaD
Penbutolol—Body temperature increased—Doxorubicin—prostate cancer	0.000118	0.000639	CcSEcCtD
Penbutolol—Asthenia—Epirubicin—prostate cancer	0.000115	0.000626	CcSEcCtD
Penbutolol—Diarrhoea—Epirubicin—prostate cancer	0.00011	0.000597	CcSEcCtD
Penbutolol—Asthenia—Doxorubicin—prostate cancer	0.000107	0.00058	CcSEcCtD
Penbutolol—Dizziness—Epirubicin—prostate cancer	0.000106	0.000577	CcSEcCtD
Penbutolol—Diarrhoea—Doxorubicin—prostate cancer	0.000102	0.000553	CcSEcCtD
Penbutolol—Headache—Epirubicin—prostate cancer	0.000101	0.000547	CcSEcCtD
Penbutolol—Dizziness—Doxorubicin—prostate cancer	9.85e-05	0.000534	CcSEcCtD
Penbutolol—Nausea—Epirubicin—prostate cancer	9.56e-05	0.000519	CcSEcCtD
Penbutolol—Headache—Doxorubicin—prostate cancer	9.33e-05	0.000506	CcSEcCtD
Penbutolol—Nausea—Doxorubicin—prostate cancer	8.84e-05	0.00048	CcSEcCtD
Penbutolol—HTR1B—Signaling Pathways—HIF1A—prostate cancer	7.88e-06	0.00027	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CD—prostate cancer	7.87e-06	0.00027	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VAV3—prostate cancer	7.86e-06	0.000269	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ITPR1—prostate cancer	7.8e-06	0.000267	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFBR2—prostate cancer	7.75e-06	0.000265	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	7.73e-06	0.000265	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LEP—prostate cancer	7.69e-06	0.000263	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ITPR1—prostate cancer	7.63e-06	0.000261	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1R—prostate cancer	7.62e-06	0.000261	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CAV1—prostate cancer	7.62e-06	0.000261	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	7.59e-06	0.00026	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CB—prostate cancer	7.56e-06	0.000259	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—JAK2—prostate cancer	7.55e-06	0.000259	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KDR—prostate cancer	7.54e-06	0.000258	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1R—prostate cancer	7.46e-06	0.000255	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	7.43e-06	0.000254	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—JAK2—prostate cancer	7.39e-06	0.000253	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ESR1—prostate cancer	7.35e-06	0.000252	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LPL—prostate cancer	7.31e-06	0.00025	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1R—prostate cancer	7.29e-06	0.00025	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL8—prostate cancer	7.26e-06	0.000249	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—IL2—prostate cancer	7.25e-06	0.000248	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	7.24e-06	0.000248	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—JAK2—prostate cancer	7.22e-06	0.000247	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	7.17e-06	0.000246	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—BAD—prostate cancer	7.17e-06	0.000246	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LPL—prostate cancer	7.15e-06	0.000245	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	7.1e-06	0.000243	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	7.09e-06	0.000243	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	7.06e-06	0.000242	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	7.02e-06	0.00024	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LPL—prostate cancer	6.99e-06	0.000239	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APC—prostate cancer	6.94e-06	0.000238	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CG—prostate cancer	6.94e-06	0.000238	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—IL2—prostate cancer	6.94e-06	0.000238	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDGFRB—prostate cancer	6.93e-06	0.000237	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	6.91e-06	0.000237	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	6.89e-06	0.000236	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IRS1—prostate cancer	6.86e-06	0.000235	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGF—prostate cancer	6.86e-06	0.000235	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CB—prostate cancer	6.86e-06	0.000235	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	6.85e-06	0.000235	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	6.84e-06	0.000234	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ITGB3—prostate cancer	6.75e-06	0.000231	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	6.74e-06	0.000231	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	6.7e-06	0.000229	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	6.69e-06	0.000229	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GSK3B—prostate cancer	6.66e-06	0.000228	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—prostate cancer	6.59e-06	0.000226	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL2—prostate cancer	6.59e-06	0.000226	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—INS—prostate cancer	6.57e-06	0.000225	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TERT—prostate cancer	6.56e-06	0.000225	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ERBB3—prostate cancer	6.55e-06	0.000224	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGFR2—prostate cancer	6.54e-06	0.000224	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	6.44e-06	0.000221	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CREBBP—prostate cancer	6.44e-06	0.00022	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TERT—prostate cancer	6.42e-06	0.00022	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—prostate cancer	6.36e-06	0.000218	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—EGFR—prostate cancer	6.33e-06	0.000217	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL2—prostate cancer	6.3e-06	0.000216	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TERT—prostate cancer	6.28e-06	0.000215	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	6.28e-06	0.000215	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAP2K1—prostate cancer	6.14e-06	0.00021	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	6.14e-06	0.00021	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—prostate cancer	6.13e-06	0.00021	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CD—prostate cancer	6.1e-06	0.000209	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	6.07e-06	0.000208	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3CA—prostate cancer	6.05e-06	0.000207	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—prostate cancer	6.04e-06	0.000207	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HIF1A—prostate cancer	6e-06	0.000206	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KDR—prostate cancer	6e-06	0.000206	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—prostate cancer	5.99e-06	0.000205	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—KRAS—prostate cancer	5.98e-06	0.000205	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	5.94e-06	0.000203	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KDR—prostate cancer	5.87e-06	0.000201	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—prostate cancer	5.86e-06	0.000201	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	5.85e-06	0.0002	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FGF2—prostate cancer	5.84e-06	0.0002	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CAV1—prostate cancer	5.81e-06	0.000199	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOS3—prostate cancer	5.76e-06	0.000197	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KDR—prostate cancer	5.74e-06	0.000197	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	5.72e-06	0.000196	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—BAD—prostate cancer	5.71e-06	0.000196	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—JAK2—prostate cancer	5.6e-06	0.000192	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ESR1—prostate cancer	5.6e-06	0.000192	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—BAD—prostate cancer	5.59e-06	0.000191	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APC—prostate cancer	5.53e-06	0.000189	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	5.53e-06	0.000189	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CA—prostate cancer	5.49e-06	0.000188	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MDM2—prostate cancer	5.47e-06	0.000187	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGF—prostate cancer	5.47e-06	0.000187	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	5.47e-06	0.000187	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—BAD—prostate cancer	5.46e-06	0.000187	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	5.41e-06	0.000185	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APC—prostate cancer	5.41e-06	0.000185	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ERBB2—prostate cancer	5.39e-06	0.000185	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	5.35e-06	0.000183	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGF—prostate cancer	5.35e-06	0.000183	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CB—prostate cancer	5.32e-06	0.000182	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	5.31e-06	0.000182	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APC—prostate cancer	5.29e-06	0.000181	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CG—prostate cancer	5.29e-06	0.000181	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—INS—prostate cancer	5.23e-06	0.000179	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGF—prostate cancer	5.23e-06	0.000179	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IRS1—prostate cancer	5.23e-06	0.000179	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	5.19e-06	0.000178	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	5.13e-06	0.000176	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—INS—prostate cancer	5.12e-06	0.000175	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—prostate cancer	5.11e-06	0.000175	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GSK3B—prostate cancer	5.08e-06	0.000174	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	5.06e-06	0.000173	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	5.04e-06	0.000173	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	5.02e-06	0.000172	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—INS—prostate cancer	5.01e-06	0.000171	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1B—prostate cancer	4.99e-06	0.000171	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	4.95e-06	0.00017	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—prostate cancer	4.94e-06	0.000169	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	4.93e-06	0.000169	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CREBBP—prostate cancer	4.9e-06	0.000168	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CASP3—prostate cancer	4.89e-06	0.000168	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	4.89e-06	0.000168	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL2—prostate cancer	4.89e-06	0.000167	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—prostate cancer	4.86e-06	0.000167	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	4.86e-06	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—prostate cancer	4.84e-06	0.000166	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EGFR—prostate cancer	4.82e-06	0.000165	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	4.82e-06	0.000165	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	4.81e-06	0.000165	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	4.79e-06	0.000164	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCND1—prostate cancer	4.76e-06	0.000163	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	4.76e-06	0.000163	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	4.76e-06	0.000163	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CTNNB1—prostate cancer	4.72e-06	0.000162	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	4.71e-06	0.000161	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	4.7e-06	0.000161	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAP2K1—prostate cancer	4.68e-06	0.00016	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	4.66e-06	0.000159	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	4.65e-06	0.000159	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CD—prostate cancer	4.65e-06	0.000159	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—prostate cancer	4.62e-06	0.000158	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN1A—prostate cancer	4.61e-06	0.000158	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CA—prostate cancer	4.61e-06	0.000158	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—prostate cancer	4.6e-06	0.000158	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PTEN—prostate cancer	4.6e-06	0.000157	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	4.59e-06	0.000157	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	4.55e-06	0.000156	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—KRAS—prostate cancer	4.55e-06	0.000156	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	4.49e-06	0.000154	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—prostate cancer	4.49e-06	0.000154	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	4.46e-06	0.000153	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF2—prostate cancer	4.45e-06	0.000152	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOS3—prostate cancer	4.39e-06	0.00015	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EP300—prostate cancer	4.38e-06	0.00015	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	4.37e-06	0.00015	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	4.36e-06	0.000149	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	4.36e-06	0.000149	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	4.29e-06	0.000147	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	4.28e-06	0.000146	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—JAK2—prostate cancer	4.27e-06	0.000146	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SRC—prostate cancer	4.26e-06	0.000146	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	4.26e-06	0.000146	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	4.24e-06	0.000145	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	4.2e-06	0.000144	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	4.18e-06	0.000143	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MDM2—prostate cancer	4.17e-06	0.000143	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—prostate cancer	4.15e-06	0.000142	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	4.15e-06	0.000142	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—STAT3—prostate cancer	4.11e-06	0.000141	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ERBB2—prostate cancer	4.11e-06	0.000141	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	4.07e-06	0.000139	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	4.05e-06	0.000139	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	3.98e-06	0.000136	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	3.98e-06	0.000136	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	3.93e-06	0.000135	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	3.9e-06	0.000133	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—prostate cancer	3.89e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL2—prostate cancer	3.89e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	3.89e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	3.87e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	3.85e-06	0.000132	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MYC—prostate cancer	3.82e-06	0.000131	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	3.81e-06	0.000131	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—prostate cancer	3.81e-06	0.000131	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL2—prostate cancer	3.81e-06	0.00013	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	3.8e-06	0.00013	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	3.79e-06	0.00013	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	3.79e-06	0.00013	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	3.76e-06	0.000129	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	3.76e-06	0.000129	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGFR—prostate cancer	3.74e-06	0.000128	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CASP3—prostate cancer	3.73e-06	0.000128	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL2—prostate cancer	3.72e-06	0.000127	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	3.71e-06	0.000127	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—prostate cancer	3.7e-06	0.000127	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	3.68e-06	0.000126	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	3.67e-06	0.000126	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	3.67e-06	0.000126	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	3.66e-06	0.000125	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCND1—prostate cancer	3.63e-06	0.000124	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	3.6e-06	0.000123	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	3.59e-06	0.000123	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	3.59e-06	0.000123	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	3.58e-06	0.000123	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	3.57e-06	0.000122	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KRAS—prostate cancer	3.53e-06	0.000121	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—prostate cancer	3.52e-06	0.000121	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	3.51e-06	0.00012	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTEN—prostate cancer	3.5e-06	0.00012	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	3.49e-06	0.00012	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EP300—prostate cancer	3.49e-06	0.00012	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—prostate cancer	3.42e-06	0.000117	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EP300—prostate cancer	3.42e-06	0.000117	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SRC—prostate cancer	3.4e-06	0.000116	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EP300—prostate cancer	3.34e-06	0.000114	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SRC—prostate cancer	3.32e-06	0.000114	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	3.31e-06	0.000113	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	3.27e-06	0.000112	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SRC—prostate cancer	3.25e-06	0.000111	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	3.24e-06	0.000111	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	3.24e-06	0.000111	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	3.2e-06	0.00011	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—prostate cancer	3.16e-06	0.000108	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TP53—prostate cancer	3.14e-06	0.000107	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT3—prostate cancer	3.13e-06	0.000107	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MYC—prostate cancer	3.04e-06	0.000104	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	3.04e-06	0.000104	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MYC—prostate cancer	2.98e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	2.98e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	2.97e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	2.91e-06	9.97e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MYC—prostate cancer	2.91e-06	9.97e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—prostate cancer	2.9e-06	9.94e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—prostate cancer	2.87e-06	9.84e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGFR—prostate cancer	2.85e-06	9.75e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	2.81e-06	9.63e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	2.75e-06	9.42e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KRAS—prostate cancer	2.69e-06	9.21e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—prostate cancer	2.65e-06	9.07e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	2.58e-06	8.85e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	2.53e-06	8.65e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TP53—prostate cancer	2.5e-06	8.56e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	2.47e-06	8.46e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TP53—prostate cancer	2.44e-06	8.37e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TP53—prostate cancer	2.39e-06	8.19e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—prostate cancer	2.29e-06	7.83e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—prostate cancer	2.24e-06	7.66e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—prostate cancer	2.19e-06	7.49e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	2.11e-06	7.23e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	2.06e-06	7.07e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—prostate cancer	2.02e-06	6.91e-05	CbGpPWpGaD
